Cassidy F, Ahearn E, Carroll BJ: Elevated frequency of diabetes mellitus in hospitalized manic-depressive patients. Am J Psychiatry. 1999, 156: 1417-1420.
CAS
PubMed
Google Scholar
Lilliker SL: Prevalence of diabetes in a manic-depressive population. Compr Psychiatry. 1980, 21: 270-275. 10.1016/0010-440X(80)90030-9.
Article
CAS
PubMed
Google Scholar
Regenold WT, Thapar RK, Marano C, Gavirneni S, Kondapavuluru PV: Increased prevalence of type 2 diabetes mellitus among psychiatric inpatients with bipolar I affective and schizoaffective disorders independent of psychotropic drug use. J Affect Disord. 2002, 70: 19-26. 10.1016/S0165-0327(01)00456-6.
Article
PubMed
Google Scholar
Fiedorowicz JG, Palagummi NM, Forman-Hoffman VL, Miller DD, Haynes WG: Elevated prevalence of obesity, metabolic syndrome, and cardiovascular risk factors in bipolar disorder. Ann Clin Psychiatry. 2008, 20: 131-137. 10.1080/10401230802177722.
Article
PubMed
PubMed Central
Google Scholar
Hert MD, Dekker JM, Wood D, Kahl KG, Holt RIG, Möller HJ: Cardiovascular disease and diabetes in people with severe mental illness position statement from the European Psychiatric Association (EPA), supported by the European Association for the Study of Diabetes (EASD) and the European Society of Cardiology (ESC). Eur Psychiatry. 2009, 24: 412-424. 10.1016/j.eurpsy.2009.01.005.
Article
PubMed
Google Scholar
Berge LI, Riise T, Fasmer OB, Lund A, Oedegaard KJ, Hundal O: Risk of depression in diabetes is highest for young persons using oral anti-diabetic agents. Diabet Med. 2011, 29: 509-514.
Article
Google Scholar
Fasmer OB, Riise T, Eagan TM, Lund A, Dilsaver SC, Hundal O, Oedegaard KJ: Comorbidity of asthma with ADHD. J Atten Disord. 2011, 15: 564-571. 10.1177/1087054710372493.
Article
PubMed
Google Scholar
Furu K: Establishment of the nationwide Norwegian Prescription Database (NorPD) - new opportunities for research in pharmacoepidemiology in Norway. Norsk Epidemiol. 2008, 18: 129-136.
Google Scholar
Oedegaard KJ, Riise T, Dilsaver SC, Lund A, Akiskal HS, Fasmer OB, Hundal O: A pharmaco-epidemiological study of migraine and antidepressant medications: complete one year data from the Norwegian population. J Affect Disord. 2011, 129: 198-204. 10.1016/j.jad.2010.09.009.
Article
PubMed
Google Scholar
Ruzickova M, Slaney C, Garnham J, Alda M: Clinical features of bipolar disorder with and without comorbid diabetes mellitus. Can J Psychiatry. 2003, 48: 458-461.
PubMed
Google Scholar
Carney CP, Jones LE: Medical comorbidity in women and men with bipolar disorders: a population-based controlled study. Psychosom Med. 2006, 68: 684-691. 10.1097/01.psy.0000237316.09601.88.
Article
PubMed
Google Scholar
Kessing LV, Nilsson FM, Siersma V, Andersen PK: Increased risk of developing diabetes in depressive and bipolar disorders?. J Psychiatr Res. 2004, 38: 395-402. 10.1016/j.jpsychires.2003.12.001.
Article
PubMed
Google Scholar
McIntyre RS, Konarski JZ, Misener VL, Kennedy SH: Bipolar disorder and diabetes mellitus: epidemiology, etiology, and treatment implications. Ann Clin Psychiatry. 2005, 17: 83-93. 10.1080/10401230590932380.
Article
PubMed
Google Scholar
Dessein PH, Stanwix AE, Joffe BI: Cardiovascular risk in rheumatoid arthritis versus osteoarthritis: acute phase response related decreased insulin sensitivity and high-density lipoprotein cholesterol as well as clustering of metabolic syndrome features in rheumatoid arthritis. Arthritis Res. 2002, 4: R5-10.1186/ar428.
Article
PubMed
PubMed Central
Google Scholar
Silveri F, Brecciaroli D, Argentati F, Cervini C: Serum levels of insulin in overweight patients with osteoarthritis of the knee. J Rheumatol. 1994, 21: 1899-1902.
CAS
PubMed
Google Scholar
Sturmer T, Brenner H, Brenner RE, Gunther KP: Non-insulin dependent diabetes mellitus (NIDDM) and patterns of osteoarthritis. The Ulm Osteoarthritis Study. Scand J Rheumatol. 2001, 30: 169-171. 10.1080/030097401300162969.
Article
CAS
PubMed
Google Scholar
Pasco JA, Nicholson GC, Ng F, Henry MJ, Williams LJ, Kotowicz MA, Hodge JM, Dodd S, Kapczinski F, Gama CG, Berk M: Oxidative stress may be a common mechanism linking major depression and osteoporosis. Acta Neuropsychiatrica. 2008, 20: 112-116. 10.1111/j.1601-5215.2008.00283.x.
Article
PubMed
Google Scholar
Chen G, Huang L, Y J, HK M: The Mood-Stabilizing Agent Valproate Inhibits the Activity of Glycogen Synthase Kinase-3. J Neurochem. 2008, 72: 1327-1330. 10.1046/j.1471-4159.2000.0721327.x.
Article
Google Scholar
Ryves WJ, Harwood AJ: Lithium inhibits glycogen synthase kinase-3 by competition for magnesium. Biochem Biophys Res Commun. 2001, 280: 720-725. 10.1006/bbrc.2000.4169.
Article
CAS
PubMed
Google Scholar
Maes M, Leonard B, Fernandez A, Kubera M, Nowak G, Veerhuis R, Gardner A, Ruckoanich P, Geffard M, Altamura C, Galecki P, Berk M: (Neuro)inflammation and neuroprogression as new pathways and drug targets in depression: from antioxidants to kinase inhibitors. Prog Neuropsychopharmacol Biol Psychiatry. 2011, 35: 659-663. 10.1016/j.pnpbp.2011.02.019.
Article
CAS
PubMed
Google Scholar
Pasco JA, Nicholson GC, Williams LJ, Jacka FN, Henry MJ, Kotowicz MA, Schneider HG, Leonard BE, Berk M: Association of high-sensitivity C-reactive protein with de novo major depression. Br J Psychiatry. 2010, 197: 372-377. 10.1192/bjp.bp.109.076430.
Article
PubMed
Google Scholar
Carulli L, Rondinella S, Lombardini S, Canedi I, Loria P, Carulli N: Review article: diabetes, genetics and ethnicity. Aliment Pharmacol Ther. 2005, 22: 16-19. 10.1111/j.1365-2036.2005.02588.x.
Article
PubMed
Google Scholar
Craddock N, Sklar P: Genetics of bipolar disorder: successful start to a long journey. Trends Genet. 2009, 25: 99-105. 10.1016/j.tig.2008.12.002.
Article
CAS
PubMed
Google Scholar
Haack S, Seeringer A, Thürmann PA, Becker T, Kircheiner J: Sex-specific differences in side effects on psychotropic drugs: genes or gender?. Pharmacogenomics. 2009, 10: 1511-1526. 10.2217/pgs.09.102.
Article
CAS
PubMed
Google Scholar
Dixon L, Wieden P, Delahanty J, Goldberg R, Postrado L, Lucksted A, Lehman A: Prevalence and correlates of diabetes in national schizophrenia samples. Schizophr Bull. 2000, 26: 903-912. 10.1093/oxfordjournals.schbul.a033504.
Article
CAS
PubMed
Google Scholar
Gallego JA, Bonetti J, Zhang J, Kane JM, Correll CU: Prevalence and correlates of antipsychotic polypharmacy: a systematic review and meta-regression of global and regional trends from the 1970s to 2009. Schizophr Res. 2012, 138: 18-28. 10.1016/j.schres.2012.03.018.
Article
PubMed
PubMed Central
Google Scholar
Clark RE, Bartels SJ, Mellman TA, Peacock WJ: Recent trends in antipsychotic combination therapy of schizophrenia and schizoaffective disorders: Implications for state mental health policy. Schizophr Bull. 2002, 28: 75-84. 10.1093/oxfordjournals.schbul.a006928.
Article
PubMed
Google Scholar
Smith M, Hopkins D, Peveler RC, Holt RI, Woodward M, Ismail K: First- v. second-generation antipsychotics and risk for diabetes in schizophrenia: systematic review and meta-analysis. Br J Psychiatry. 2008, 192: 406-411. 10.1192/bjp.bp.107.037184.
Article
CAS
PubMed
Google Scholar